Elevated Stress Hormone Levels Relate to Epstein-Barr Virus Reactivation in Astronauts

Objective The objective of this study was to determine the effects of stress and spaceflight on levels of neuroendocrine hormones and Epstein-Barr virus (EBV)–specific antibodies in astronauts. Methods Antiviral antibody titers and stress hormones were measured in plasma samples collected from 28 astronauts at their annual medical exam (baseline), 10 days before launch (L−10), landing day (R+0), and 3 days after landing (R+3). Urinary stress hormones were also measured at L−10 and R+0. Results Significant increases (p < .01) in EBV virus capsid antigen antibodies were found at all three time points (L−10, R+0, and R+3) as compared with baseline samples. Anti-EBV nuclear antigen antibodies were significantly decreased at L−10 (p < .05) and continued to decrease after spaceflight (R+0 and R+3, p < .01). No changes were found in antibodies to the nonlatent measles virus. The 11 astronauts who showed evidence of EBV reactivation had significant increases in urinary epinephrine and norepinephrine as compared with astronauts without EBV reactivation. Conclusion These findings indicate that physical and psychological stresses associated with spaceflight resulted in decreased virus-specific T-cell immunity and reactivation of EBV.

[1]  W. Summers,et al.  Identification of a glucocorticoid-responsive element in Epstein-Barr virus , 1990, Journal of virology.

[2]  M. Eaman Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[3]  A Cogoli,et al.  Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. , 1994, Aviation, space, and environmental medicine.

[4]  A. Fauci,et al.  The clinical use of glucocorticoids. , 1983, Annals of allergy.

[5]  Carolyn S. Leach Huntoon,et al.  Humans in Spaceflight , 1996 .

[6]  W. Malarkey,et al.  Stress‐induced modulation of the immune response to recombinant hepatitis B vaccine. , 1992, Psychosomatic medicine.

[7]  Daniel L. Feeback,et al.  Stress-Induced Reactivation of Epstein-Barr Virus in Astronauts , 2000, Neuroimmunomodulation.

[8]  G Sonnenfeld,et al.  Changes in the immune system during and after spaceflight. , 1997, Advances in space biology and medicine.

[9]  G R Taylor,et al.  In vivo testing confirms a blunting of the human cell‐mediated immune mechanism during space flight , 1992, Journal of leukocyte biology.

[10]  J. Sheridan,et al.  Stress and immunity: implications for viral disease and wound healing. , 1999, Journal of periodontology.

[11]  J I Leonard,et al.  Regulation of body fluid compartments during short-term spaceflight. , 1996, Journal of applied physiology.

[12]  T P Stein,et al.  Excretion of IL-6 by astronauts during spaceflight. , 1994, The American journal of physiology.

[13]  G R Taylor,et al.  Immunological analyses of U.S. Space Shuttle crewmembers. , 1986, Aviation, space, and environmental medicine.

[14]  D. Tyrrell,et al.  Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. , 1992, The Journal of infectious diseases.

[15]  Daniel L. Feeback,et al.  Leukocyte subsets and neutrophil function after short‐term spaceflight , 1999, Journal of leukocyte biology.

[16]  Kehrl Jh,et al.  The clinical use of glucocorticoids. , 1983 .

[17]  C. G. Blomqvist,et al.  Orthostatic intolerance after spaceflight. , 1996, Journal of applied physiology.

[18]  D. Umetsu,et al.  Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. , 1997, Journal of immunology.

[19]  C. Sams,et al.  The role of psychoneuroendocrine factors on spaceflight‐induced immunological alterations , 1993, Journal of leukocyte biology.

[20]  M. Amstey Genital herpesvirus infection. , 1975, Clinical obstetrics and gynecology.

[21]  J. Sheridan,et al.  Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice , 1991, Journal of Neuroimmunology.

[22]  A D Moore,et al.  Inflight exercise affects stand test responses after space flight. , 1999, Medicine and science in sports and exercise.

[23]  J. Sheridan,et al.  Mechanisms of stress-induced modulation of viral pathogenesis and immunity , 1993, Journal of Neuroimmunology.

[24]  R. MacCallum,et al.  Hormonal modulation of Epstein-Barr virus replication. , 1995, Neuroendocrinology.

[25]  S. Riddler,et al.  Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. , 1994, Blood.

[26]  D. Papanicolaou,et al.  Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.

[27]  Harold Sandler,et al.  Inactivity: Physiological Effects , 1987 .

[28]  M. Akiyama,et al.  A Positive Correlation between the Precursor Frequency of Cytotoxic Lymphocytes to Autologous Epstein‐Barr Virus‐Transformed B Cells and Antibody Titer Level against Epstein‐Barr Virus‐Associated Nuclear Antigen in Healthy Seropositive Individuals , 1993, Microbiology and immunology.

[29]  D. Umetsu,et al.  Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. , 1998, Journal of immunology.

[30]  B. Griffith,et al.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. , 1985, The Journal of infectious diseases.

[31]  Jack R. Davis,et al.  Epstein-Barr virus and human diseases: recent advances in diagnosis , 1988, Clinical Microbiology Reviews.

[32]  S. Chasserot-Golaz,et al.  Activation of Epstein‐Barr virus promoters by a growth‐factor and a glucocorticoid , 1991, FEBS letters.